Skip to content

ALBIREO PHARMA, INC.: filings

Every ALBIREO PHARMA, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 47 filings, each linked to its SEC index.

Filing record ends 2022-11-08

The latest filing in this captured record is a 10-Q filed 2022-11-08. No later filing is in the SEC companyfacts record captured on 2026-09-22. ALBIREO PHARMA, INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2022-11-08fiscal Q3 2022441270001558370-22-016893
10-Q2022-08-15fiscal Q2 2022401070001558370-22-013652
10-Q2022-05-16fiscal Q1 202240800001558370-22-008984
10-K2022-03-01fiscal FY 2021541030001558370-22-002501
10-Q2021-11-04fiscal Q3 2021471300001558370-21-014469
10-Q2021-08-05fiscal Q2 2021391090001558370-21-010431
10-Q2021-05-06fiscal Q1 202133690001558370-21-006101
10-K2021-02-25fiscal FY 202046900001558370-21-001730
10-Q2020-11-05fiscal Q3 202034940001558370-20-012727
10-Q2020-08-06fiscal Q2 202034900001558370-20-009519
10-Q2020-05-07fiscal Q1 202032670001558370-20-005554
10-K2020-03-02fiscal FY 201943820001558370-20-001905
10-Q2019-11-06fiscal Q3 201937980001558370-19-010084
10-Q2019-08-08fiscal Q2 201935910001558370-19-007596
10-Q2019-05-09fiscal Q1 201935690001558370-19-004584
10-K2019-03-06fiscal FY 201840840001558370-19-001601
10-Q2018-11-08fiscal Q3 201836910001558370-18-009015
10-Q2018-08-09fiscal Q2 201835910001564590-18-020960
10-Q2018-05-10fiscal Q1 201834670001564590-18-012934
10-K2018-03-27fiscal FY 201738750001564590-18-006847
10-Q2017-11-14fiscal Q3 201736980001564590-17-023765
10-Q2017-08-21fiscal Q2 201736980001564590-17-017854
10-Q2017-05-11fiscal Q1 201731640001564590-17-010510
10-K2017-03-27fiscal FY 201638730001564590-17-005341
10-K2016-12-22fiscal FY 201628560001564590-16-030440
10-Q2016-08-11fiscal Q3 201626650001145443-16-002033
10-Q2016-05-10fiscal Q2 201626650001145443-16-001794
10-Q2016-02-16fiscal Q1 201625520001145443-16-001498
10-K2015-12-22fiscal FY 201533660001145443-15-001341
10-Q2015-08-14fiscal Q3 201526660001145443-15-000988
10-Q2015-06-01fiscal Q2 201526660001145443-15-000768
10-Q2015-05-07fiscal Q2 201526660001145443-15-000645
10-Q2015-02-12fiscal Q1 201525520001145443-15-000217
10-K2014-12-19fiscal FY 201432640001145443-14-001571
10-Q2014-08-13fiscal Q3 201427660001145443-14-001063
10-Q2014-05-14fiscal Q2 2014291110001145443-14-000763
10-Q2014-02-10fiscal Q1 201429950001145443-14-000138
10-K2013-12-20fiscal FY 2013341240001145443-13-002284
10-Q2013-08-14fiscal Q3 2013291010001145443-13-001691
10-Q2013-05-13fiscal Q2 2013291020001145443-13-001314
10-Q2013-02-14fiscal Q1 201328850001145443-13-000396
10-K2012-12-21fiscal FY 2012401410001145443-12-001417
10-Q/A2012-09-12fiscal Q3 2012301000001145443-12-001056
10-Q2012-05-15fiscal Q2 2012301030001145443-12-000728
10-Q2012-02-09fiscal Q1 201230850001145443-12-000102
10-K2011-12-15fiscal FY 2011311020001145443-11-001243
10-Q2011-08-09fiscal Q3 2011311010001145443-11-000747

Inspect the source

Entity
ALBIREO PHARMA, INC. / CIK 0001322505
Captured
SEC response SHA-256
ad9ae766a344b9e48bac71697c9aedc60a625b992df2c801aab8508f319ca4d7

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001322505.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))